• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体调节剂对中枢神经系统细胞骨架蛋白的影响。

Effects of estrogen receptor modulators on cytoskeletal proteins in the central nervous system.

作者信息

Segura-Uribe Julia J, Pinto-Almazán Rodolfo, Coyoy-Salgado Angélica, Fuentes-Venado Claudia E, Guerra-Araiza Christian

机构信息

Unidad de Investigación Médica en Enfermedades Neurológicas, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico.

出版信息

Neural Regen Res. 2017 Aug;12(8):1231-1240. doi: 10.4103/1673-5374.213536.

DOI:10.4103/1673-5374.213536
PMID:28966632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5607812/
Abstract

Estrogen receptor modulators are compounds of interest because of their estrogenic agonistic/antagonistic effects and tissue specificity. These compounds have many clinical applications, particularly for breast cancer treatment and osteoporosis in postmenopausal women, as well as for the treatment of climacteric symptoms. Similar to estrogens, neuroprotective effects of estrogen receptor modulators have been described in different models. However, the mechanisms of action of these compounds in the central nervous system have not been fully described. We conducted a systematic search to investigate the effects of estrogen receptor modulators in the central nervous system, focusing on the modulation of cytoskeletal proteins. We found that raloxifene, tamoxifen, and tibolone modulate some cytoskeletal proteins such as tau, microtuble-associated protein 1 (MAP1), MAP2, neurofilament 38 (NF38) by different mechanisms of action and at different levels: neuronal microfilaments, intermediate filaments, and microtubule-associated proteins. Finally, we emphasize the importance of the study of these compounds in the treatment of neurodegenerative diseases since they present the benefits of estrogens without their side effects.

摘要

雌激素受体调节剂因其雌激素激动/拮抗作用和组织特异性而备受关注。这些化合物有许多临床应用,特别是用于治疗绝经后女性的乳腺癌和骨质疏松症,以及缓解更年期症状。与雌激素类似,在不同模型中已描述了雌激素受体调节剂的神经保护作用。然而,这些化合物在中枢神经系统中的作用机制尚未完全阐明。我们进行了一项系统检索,以研究雌激素受体调节剂在中枢神经系统中的作用,重点关注细胞骨架蛋白的调节。我们发现雷洛昔芬、他莫昔芬和替勃龙通过不同的作用机制和在不同水平(神经元微丝、中间丝和微管相关蛋白)调节一些细胞骨架蛋白,如tau、微管相关蛋白1(MAP1)、MAP2、神经丝38(NF38)。最后,我们强调研究这些化合物在治疗神经退行性疾病中的重要性,因为它们具有雌激素的益处而无其副作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc1/5607812/88cfc4bfc426/NRR-12-1231-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc1/5607812/ec3804ae3bd4/NRR-12-1231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc1/5607812/769f6a9e7f80/NRR-12-1231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc1/5607812/88cfc4bfc426/NRR-12-1231-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc1/5607812/ec3804ae3bd4/NRR-12-1231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc1/5607812/769f6a9e7f80/NRR-12-1231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc1/5607812/88cfc4bfc426/NRR-12-1231-g003.jpg

相似文献

1
Effects of estrogen receptor modulators on cytoskeletal proteins in the central nervous system.雌激素受体调节剂对中枢神经系统细胞骨架蛋白的影响。
Neural Regen Res. 2017 Aug;12(8):1231-1240. doi: 10.4103/1673-5374.213536.
2
Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments.骨质疏松症现有治疗方式的利弊:替勃龙、选择性雌激素受体调节剂及雌激素(±孕激素)治疗的比较
J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):157-65. doi: 10.1016/s0960-0760(03)00055-4.
3
Selective estrogen modulators in menopause.绝经中的选择性雌激素调节剂
Minerva Ginecol. 2013 Dec;65(6):621-30.
4
Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.激素替代疗法、选择性雌激素受体调节剂和组织特异性化合物:心血管效应及临床意义。
Treat Endocrinol. 2004;3(2):105-15. doi: 10.2165/00024677-200403020-00005.
5
Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.选择性雌激素受体调节剂及结合雌激素/巴多昔芬联合疗法:对乳腺影响的综述
Post Reprod Health. 2015 Sep;21(3):112-21. doi: 10.1177/2053369115599090. Epub 2015 Aug 19.
6
Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovine.选择性雌激素受体调节剂和雌激素对绵羊乳腺血流的不同影响。
Am J Obstet Gynecol. 2002 Dec;187(6):1555-60. doi: 10.1067/mob.2002.127600.
7
Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer.选择性雌激素受体调节剂:寻找理想的乳腺癌激素疗法。
Cancer Invest. 2001;19(6):649-59. doi: 10.1081/cnv-100104293.
8
Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators.超越雌激素:组织选择性雌激素复合物和选择性雌激素受体调节剂的进展。
Climacteric. 2019 Apr;22(2):140-147. doi: 10.1080/13697137.2019.1568403.
9
Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study.绝经后女性中与雷洛昔芬和替勃龙治疗相关的乳房X线变化:一项前瞻性研究。
Menopause. 2002 Mar-Apr;9(2):110-6. doi: 10.1097/00042192-200203000-00005.
10
The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.选择性雌激素受体调节剂在乳腺癌中的作用:从他莫昔芬到雷洛昔芬。
Taiwan J Obstet Gynecol. 2008 Mar;47(1):24-31. doi: 10.1016/S1028-4559(08)60051-0.

引用本文的文献

1
Osteoporosis treatment: current drugs and future developments.骨质疏松症的治疗:当前药物与未来发展
Front Pharmacol. 2024 Aug 12;15:1456796. doi: 10.3389/fphar.2024.1456796. eCollection 2024.
2
Discovering biomarkers for hormone-dependent tumors: in silico study on signaling pathways implicated in cell cycle and cytoskeleton regulation.发现激素依赖性肿瘤的生物标志物:细胞周期和细胞骨架调节相关信号通路的计算研究。
Mol Genet Genomics. 2022 Jul;297(4):947-963. doi: 10.1007/s00438-022-01900-7. Epub 2022 May 9.
3
The Role of 17β-Estrogen in Escherichia coli Adhesion on Human Vaginal Epithelial Cells via FAK Phosphorylation.

本文引用的文献

1
Tibolone modulates neuronal plasticity through regulating Tau, GSK3β/Akt/PI3K pathway and CDK5 p35/p25 complexes in the hippocampus of aged male mice.替勃龙通过调节老年雄性小鼠海马体中的 Tau、GSK3β/Akt/PI3K 信号通路以及 CDK5 p35/p25 复合物来调节神经元可塑性。
Neural Regen Res. 2017 Apr;12(4):588-595. doi: 10.4103/1673-5374.205098.
2
Microtubule dynamics and the neurodegenerative triad of Alzheimer's disease: The hidden connection.微管动力学与阿尔茨海默病的神经退行性三联征:隐藏的联系。
J Neurochem. 2017 Nov;143(4):409-417. doi: 10.1111/jnc.14011. Epub 2017 Apr 19.
3
Effects of Tibolone on the Central Nervous System: Clinical and Experimental Approaches.
17β-雌二醇通过 FAK 磷酸化在大肠杆菌黏附于人体阴道上皮细胞中的作用。
Infect Immun. 2021 Oct 15;89(11):e0021921. doi: 10.1128/IAI.00219-21. Epub 2021 Aug 23.
4
Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.一生中雌激素暴露与进行性核上性麻痹:环境和遗传 PSP 研究。
Mov Disord. 2018 Mar;33(3):468-472. doi: 10.1002/mds.27336. Epub 2018 Feb 20.
替勃龙对中枢神经系统的影响:临床与实验方法
Biomed Res Int. 2017;2017:8630764. doi: 10.1155/2017/8630764. Epub 2017 Jan 16.
4
Estrogen Receptor Ligands: A Review (2013-2015).雌激素受体配体:综述(2013 - 2015年)
Sci Pharm. 2016 Apr 13;84(3):409-427. doi: 10.3390/scipharm84030409.
5
Selective Estrogen Receptor Modulators.选择性雌激素受体调节剂
Asian Spine J. 2016 Aug;10(4):787-91. doi: 10.4184/asj.2016.10.4.787. Epub 2016 Aug 16.
6
Microtubule plus-end tracking proteins in neuronal development.神经元发育中的微管正端追踪蛋白
Cell Mol Life Sci. 2016 May;73(10):2053-77. doi: 10.1007/s00018-016-2168-3. Epub 2016 Mar 11.
7
Building Blocks of Functioning Brain: Cytoskeletal Dynamics in Neuronal Development.功能大脑的基石:神经元发育中的细胞骨架动力学
Int Rev Cell Mol Biol. 2016;322:183-245. doi: 10.1016/bs.ircmb.2015.10.002. Epub 2016 Jan 6.
8
Sex Hormones Regulate Cytoskeletal Proteins Involved in Brain Plasticity.性激素调节参与大脑可塑性的细胞骨架蛋白。
Front Psychiatry. 2015 Nov 20;6:165. doi: 10.3389/fpsyt.2015.00165. eCollection 2015.
9
Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.少突胶质细胞中截短形式的 Tau 蛋白的诱导表达引发步态异常和髓鞘减少:对中枢神经系统选择性退行性疾病的启示。
Neurochem Res. 2015 Nov;40(11):2188-99. doi: 10.1007/s11064-015-1707-x. Epub 2015 Sep 22.
10
Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain.Akt三种亚型的条件性失活会导致大脑中tau蛋白过度磷酸化。
Mol Neurodegener. 2015 Jul 31;10:33. doi: 10.1186/s13024-015-0030-y.